Name: Renal Biomarkers Market in United States, United Kingdom – Market Outlook, Unmet Needs, Market Assessment &amp; Forecast (2023-2030)
SKU: 17648
Availability: InStock

Renal Biomarkers Market – Report Overview

Pacific Business Consulting’s “Renal Biomarkers Market in 10MM – Market Outlook, Unmet Needs, Market Assessment & Forecast (2023-2030)” report offers a comprehensive understanding of Renal Biomarkers market, encompassing historical and projected market size data, along with market trends, market drivers, market barriers and unmet medical needs in the Ten Major Markets (10MM) of the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, China, Australia, and India.

In 2022, the Renal Biomarkers market exceeded a valuation of over US$ 3.5 Billion, and it is poised for substantial growth, with a projected Compound Annual Growth Rate (CAGR) exceeding 7.0% from 2023 to 2030. The market is expected to potentially surpass US$ 6.0 Billion by 2030.

Renal biomarkers, encompassing cells, proteins, lipids, microRNAs, genes, metabolites, or proteomic patterns detected in urinalysis, play a crucial role in assessing kidney function, evaluating pathogenic processes, and gauging responses to therapeutic interventions. With applications in predicting disease progression and determining drug dosage, renal biomarkers are widely utilized in hospitals and diagnostic laboratories worldwide.

The growth of the renal biomarkers market is propelled by factors such as the increasing prevalence of kidney-related diseases, particularly driven by the high incidence of diabetes and hypertension, leading causes of renal issues. Technological advancements in genetics further contribute to the market’s expansion. According to a published article in Kidney International Supplements (April 2022), about 10% of the global population suffers from chronic kidney disease, with millions succumbing to it annually. The prevalence of chronic kidney disease is on the rise, with a heightened risk in Asian countries for diabetes-related kidney diseases. For example, India is expected to witness a significant increase in diabetes cases, reaching 92,973.7 thousand by 2030.

Advancements in genetic technology have enhanced understanding regarding genetic regulatory pathways related to renal biomarkers. Genomic technologies have become essential in clinical practice and research, facilitated by developments in computer technology, making renal biomarker testing accessible even in smaller laboratories. These genetic advances provide opportunities for studying kidney diseases on various platforms applied to human populations. Integration of renal biomarkers into genetic-level technologies for detecting, diagnosing, and treating kidney diseases has been facilitated by rapid advances in genetics.

Strategic initiatives by market players, including partnerships, mergers, acquisitions, and product launches, contribute significantly to market growth. For instance, collaborations between Renalytix AI and the Joslin Diabetes Center, leading to the incorporation of new biomarkers for kidney disease in the KidneyIntelX platform, showcase the industry’s dynamic landscape. The CE marking of BioMerieux’s NEPHROCHECK assay for detecting kidney stress in patients at risk of acute kidney injury (AKI) and positive results from Aravive Inc.’s Phase 1b/2 trial of batiraxcept in clear cell renal cell cancer (ccRCC) demonstrate the continuous development of biomarker tests.

Considering the growing burden of kidney diseases and strategic endeavors by market players, the renal biomarkers market is poised for significant growth. However, challenges related to regulatory and reimbursement systems may impede the market’s growth during the forecast period.

Leading players in the Renal Biomarkers segment, including Thermofisher Scientific, Abbott Laboratories, BioPorto Diagnostics AS, Siemens Healthineers AG, F. Hoffmann-La Roche Ltd, and BioMérieux, Sphingotec GmbH, and Enzo Biochem Inc., are expected to play a crucial role in shaping the future landscape of Renal Biomarkers technologies through ongoing innovation.

Scope of Report

The report addresses critical subjects such as strategic competitor evaluation, market characterization, unmet needs, and the consequences of these elements for the Renal Biomarkers market. It also delves into the analysis of present and prospective market competition within the global Renal Biomarkers market.

Furthermore, the report offers an insightful examination of the primary industry drivers, constraints, and challenges. Each trend undergoes independent research to furnish qualitative analysis regarding its implications.

Reasons to Buy

Develop your business strategies by gaining insights into the trends that shape and drive the Renal Biomarkers market across the 10MM (Ten Major Markets).
Increase revenue by comprehending key trends, innovative products and technologies, market segments, and companies poised to influence the future of the 10MM Renal Biomarkers market.
Craft effective sales and marketing strategies by thoroughly understanding the competitive landscape and analyzing the performance of various competitors.
Identify emerging players with potentially robust product portfolios and devise strategic counter-strategies to gain a competitive advantage.
Optimize your sales and marketing efforts by pinpointing market categories and segments that offer the greatest opportunities for consolidations, investments, and strategic partnerships.

Executive Summary: Renal Biomarkers
- Global Market Outlook: Renal Biomarkers
Competitive Intelligence Analysis: Renal Biomarkers
Therapeutic Sector SWOT
Technology Roadmap Analysis: Renal Biomarkers
Market Background
- Drivers
- Restraints
- Opportunity
- Key Market Trends
- Key Unmet Needs
Key Marketed Products Profile – Major Approved Products: Renal Biomarkers
- Product Profile
- Safety and Efficacy
Regulatory Landscape
Renal Biomarkers: Ten Major Market (10MM) – Market Analysis, By Biomarker
- Functional Biomarker
  - Serum Creatinine
  - Serum Cystatin C
  - Urine Albumin
- Up-Regulated Proteins
  - Neutrophil Gelatinase-Associated Lipocalin
  - Kidney Injury Molecule-1
  - Interleukin-18
- Others
Renal Biomarkers: Ten Major Market (10MM) – Market Analysis, By Technology
- Enzyme Linked Immunosorbent Assay (ELISA)
- Colorimetric Assay
- Chemiluminescent Enzyme Immunoassay (CLIA)
- Particle-Enhanced Turbidimetric Immunoassay (PETIA)
- Liquid Chromatography-Mass Spectrometry (LS-MS)
Renal Biomarkers: Ten Major Market (10MM) – Market Analysis, By End User
- Hospitals & Clinics
- Diagnostic Laboratories
- Academic & Research Institutes
Renal Biomarkers: Ten Major Market (10MM) – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Biomarker
  - By Technology
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Biomarker
  - By Technology
  - By End User

S. Renal Biomarkers – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Biomarker
  - By Technology
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Biomarker
  - By Technology
  - By End User

K. Renal Biomarkers – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Biomarker
  - By Technology
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Biomarker
  - By Technology
  - By End User

Germany Renal Biomarkers – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Biomarker
  - By Technology
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Biomarker
  - By Technology
  - By End User

France Renal Biomarkers – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Biomarker
  - By Technology
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Biomarker
  - By Technology
  - By End User

Italy Renal Biomarkers – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Biomarker
  - By Technology
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Biomarker
  - By Technology
  - By End User

Spain Renal Biomarkers – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Biomarker
  - By Technology
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Biomarker
  - By Technology
  - By End User

Japan Renal Biomarkers – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Biomarker
  - By Technology
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Biomarker
  - By Technology
  - By End User

China Renal Biomarkers – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Biomarker
  - By Technology
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Biomarker
  - By Technology
  - By End User

Australia Renal Biomarkers – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Biomarker
  - By Technology
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Biomarker
  - By Technology
  - By End User

India Renal Biomarkers – Market Analysis
- Historical Market Analysis (US$ million), 2020-2022
  - By Biomarker
  - By Technology
  - By End User
- Current and Future Market Projections (US$ million), 2023-2030
  - By Biomarker
  - By Technology
  - By End User

Competitive Landscape
- Company Overview
- Product Portfolio
- Key Financials
- Sales Footprint

Note – All Major Company Profiles (Count up to 20) will be covered in the report

Assumptions and Acronyms Used
Research Methodology
- Secondary Research
- Primary Research
- Data Triangulation
Geographic Scope
- The U.S., The U.K., Germany, France, Italy, Spain, Japan, China, Australia, and India
Copyrights and Disclaimer

Renal Biomarkers Market in United States, United Kingdom – Market Outlook, Unmet Needs, Market Assessment & Forecast (2023-2030)

License Type (Price in USD)

Customize Reports As Per Your Needs

Have A Question?

Phone:+919599779105
Email:info@pacificbusinessconsulting.com

RELATED PRODUCTS

Age-related Macular Degeneration (AMD) Market in United States, United Kingdom – Market Outlook, Unmet Needs, Market Assessment and Forecast (2023-2030)

Metastatic Prostate Cancer Market in United States, United Kingdom– Market Insights, Market Assessment and Market Forecast (2023-2030)

Multiple Myeloma Market in United States, United Kingdom– Market Insights, Unmet Needs, Market Assessment and Forecast (2023-2030)

Multiple Sclerosis Market in United States, United Kingdom – Market Outlook, Unmet Needs, Market Assessment and Forecast (2023-2030)

Obesity Market in United States, United Kingdom– Market Outlook, Unmet Needs, Market Assessment and Forecast (2023-2030)

Useful Links

Consulting

Get In Touch